All-polyethylene tibia PS components compared to metal-backed tibia PS components in total knee replacement

ISRCTN ISRCTN10744502
DOI https://doi.org/10.1186/ISRCTN10744502
Secondary identifying numbers K-S-046
Submission date
22/09/2014
Registration date
26/11/2014
Last edited
05/12/2023
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Metal-backed total knee replacements are the most commonly used total knee replacements all over the world. However, knee replacements with all-polyethylene tibial components remain an attractive alternative as they are cheaper and avoid problems such as the knee joint mechanism locking and some wear and tear issues. Here, we want to compare two types of total knee replacements – the Triathlon PS Knee System with all-polyethylene tibial components and the Triathlon PS Knee System with metal-backed modular tibial components.

Who can participate?
Adults aged 40 to 75 who need a total knee replacement.

What does the study involve?
Participants are randomly allocated to one of two groups. Those in group 1 receive the all-polyethylene tibial components for their total knee replacement. Those in group 2 receive the metal-backed modular tibial components for their total knee replacement. The two types of knee replacements are then compared using RSA (radiostereometric analysis) X rays. This is a special technique that takes two X-rays of the joint from different angles at the same time. This creates a 3D image that can be viewed. During surgery, tiny beads are placed in the bone that will surround the knee replacement. These beads are then used to check the positioning of the knee replacement and whether that changes over time. Each patient taking part in the study is invited to a number of follow up visits – one before being discharged from hospital, one 3 months after surgery, and then at 1, 2, 5, 7 and 10 years after surgery. During these visits, they are asked to complete questionnaires about their health, their activities and their knee. RSA X-rays are also taken.

What are the possible benefits and risks of participating?
The study will help increase knowledge of the two knee replacement systems used in the study.

Where is the study run?
Hässleholms sjukhus, Hässleholm (Sweden)

When is the study starting and how long is it expected to run for?
October 2014 to December 2025

Who is funding the study?
Stryker European Operations BV (Netherlands)

Who is the main contact?
Christina Silver
christina.silver@stryker.com

Contact information

Dr Sören Toksvig-Larsen
Scientific

Department of Orthopaedics Hässleholm-Kristianstad-Ystad
Hässleholm Hospital
Hässleholm
281 38
Sweden

Mrs Christina Silver
Public

Stryker SA
Krusegatan 19
Malmö
202 14
Sweden

Phone +46 (0)709 928119
Email christina.silver@stryker.com

Study information

Study designSingle-center randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleMigration and survival of all-polyethylene tibial components compared to the metal-backed modular components of the Triathlon PS Total Knee System. A RSA study
Study acronymN/A
Study hypothesis1. The primary objective is the assessment of prosthetic migration results after two years with the Triathlon PS Knee System with all-polyethylene tibial components compared to the Triathlon PS Knee System with metal-backed modular components by means of Roentgen Stereophotogrammetry.
2. The secondary objective will be the prediction of the long-term survival based on the two-year migration patterns combined with clinical factors and radiographic aspects. In order to identify other clinical parameters besides the fixation of the prosthesis components, clinical scores and radiographic aspects will be correlated with the RSA outcome.
Ethics approval(s)The Regional Ethical Review Board in Lund, Sweden, 02/09/2014, ref. Dnr 2014/513
ConditionOsteoarthritis
InterventionPatients are informed and screened pre-operative. Patients that comply with the inclusion/exclusion criteria and who give their consent for participation will be given a study ID. After signing Informed Consent, the patients will be randomized in one of the two groups, the day before surgery. The patient will receive either the all-polyethylene tibial component or the metal backed modular tibial component for their Triathlon PS total knee. The principal investigator and the participating surgeons may dissent from the randomization scheme based on intra-operative findings. This patient will be excluded from the study. Follow-up visits are performed at the following time points: prior to discharge, 3 months, 1, 2, 5, 7 and 10 years after surgery. During these visits clinical evaluation and x-rays are done, any adverse events are monitored (if applicable) and the KOOS, EQ-5D and FJS questionnaires are completed by the patient.
Intervention typeDevice
Pharmaceutical study type(s)Not Applicable
PhasePhase III/IV
Drug / device / biological / vaccine name(s)All-polyethylene PS Triathlon Total Knee System, Metal-backed PS Triathlon Total Knee System
Primary outcome measureThe primary outcome measure will be prosthetic migration after two years of the Triathlon PS Knee System with all-polyethylene tibial components and the Triathlon PS Knee System with metal backed modular components by means of Roentgen Stereophotogrammetry.
It is hypothesized that there will be no difference between groups. The difference in migration between components must not exceed 0.3 mm for translations and 0.25° for the rotations to determine equivalence
Secondary outcome measuresThe secondary outcome measure will be long-term survival based on the two-year migration patterns combined with clinical factors and radiographic aspects. In order to identify other clinical parameters besides the fixation of the prosthesis components, clinical scores and radiographic aspects will be correlated with the RSA outcome. The 10-year results will be used to verify the predicted long-term survival results.
Overall study start date10/09/2014
Overall study end date31/12/2025

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants60
Participant inclusion criteria1. Patient is able to understand the meaning of the study and is willing to sign the EC approved, study specific Informed Patient Consent Form
2. Patients with a pre-operative knee score of < 70
3. Patients scheduled to undergo primary total knee replacement with any of the following indication
3.1. Painful and disabled knee joint resulting from osteoarthritis
3.2. One or more compartments are involved
4. No indication for Triathlon PS
5. Need to obtain pain relief and improve function
6. Ability and willingness to follow instructions, including control of weight and activity level, and to return for follow-up evaluations
7. A good nutritional state of the patient
8. The subject is a male or non-pregnant female between 40 and 75 years of age
Participant exclusion criteria1. The subject is morbidly obese, defined as Body Mass Index (BMI) of > 40
2. Patient has a flexion contracture of 15° and more
3. Patient has a varus/valgus contracture of 15° and more
4. Patients with a pre-operative knee score of >70
5. The subject has a history of total or unicompartmental reconstruction of the affected joint
6. The subject will be operated bilaterally
7. Patients who had a Total Hip Arthroplasty (THA) on contralateral and/or ipsilateral side within the last year that is considered to have an unsatisfactory outcome (Patients with contralateral and/or ipsilateral THA > 1 year ago with good outcome can be included in the study)
8. Patients who had a Total Knee Arthroplasty (TKA) on contralateral side within the last 6 months that is considered to have an unsatisfactory outcome. (Patients with contralateral TKA > 6 months ago with good outcome can be included in the study)
9. The subject has an active or suspected latent infection in or about the knee joint
10. Osteomyelitis
11. Sepsis
12. Patient who is expected to need lower limb joint replacement for another joint within one year
13. The subject has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device
14. The subject has a systemic or metabolic disorder leading to progressive bone deterioration
15. The subject is immunologically suppressed or receiving steroids in excess of normal physiological requirements
16. The subject’s bone stock in compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis
17. The subject has had a knee fusion to the affected joint
18. Female patients planning a pregnancy during the course of the study
19. The patient is unable or unwilling to sign the Informed Consent specific to this study
Recruitment start date10/09/2014
Recruitment end date30/04/2015

Locations

Countries of recruitment

  • Sweden

Study participating centre

Department of Orthopaedics Hässleholm-Kristianstad-Ystad
Hässleholm Hospital
Hässleholm
281 38
Sweden

Sponsor information

Stryker European Operations BV (Netherlands)
Industry

Herikerbergweg 110
Amsterdam
1101 CM
Netherlands

Website http://www.stryker.com/
ROR logo "ROR" https://ror.org/02nwyam20

Funders

Funder type

Industry

Stryker European Operations BV (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 2-year results 25/09/2019 05/12/2023 Yes No
Results article 5-year results 24/01/2022 05/12/2023 Yes No

Editorial Notes

05/12/2023: The following changes were made:
1. Two publication references were added.
2. Phase and device names added.
07/09/2015: Updated recruitment end date from 31/12/2025 to 30/04/2015.

Springer Nature